Vieworks Co., Ltd. (KOSDAQ:100120)
26,600
+150 (0.57%)
Sep 11, 2026, 3:30 PM KST
Vieworks Revenue
Vieworks had revenue of 63.88B KRW in the quarter ending June 30, 2026, with 1.87% growth. This brings the company's revenue in the last twelve months to 244.28B, up 8.46% year-over-year. In the year 2025, Vieworks had annual revenue of 239.33B with 7.37% growth.
Revenue (ttm)
244.28B
Revenue Growth
+8.46%
P/S Ratio
0.94
Revenue / Employee
505.75M
Employees
483
Market Cap
230.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 239.33B | 16.44B | 7.37% |
| Dec 31, 2024 | 222.90B | 2.65B | 1.20% |
| Dec 31, 2023 | 220.25B | -17.68B | -7.43% |
| Dec 31, 2022 | 237.93B | 44.79B | 23.19% |
| Dec 31, 2021 | 193.14B | 32.88B | 20.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Value Added Technology | 441.04B |
| T&L Co., Ltd. | 175.16B |
| Boditech Med | 174.78B |
| WON TECH | 167.35B |
| Dongbang Medical | 125.12B |
| Shinhung | 105.89B |
| Bio Plus | 99.15B |
| Curexo | 77.74B |